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of normal chemotaxis, ingestion and degranulation, but unable to kill
catalase-positive microorganisms due to defects in one of the 5 major
subunits of NADPH oxidase.
Method and material: The medical records of 38 patients diagnosed with
CGDwere reviewed and analysed with respect to demographic data, age at
presentation and diagnosis, clinical features, laboratory investigations,
organisms isolated, treatment & prophylaxis given and clinical course.
Results: Our study had 28 males and 10 females with 13 having history of
consanguinity. Their mean age at presentation and diagnosis was 1.32yr
and 2.5yr respectively. The most common manifestations at presentation
were failure to thrive (100%) and lymphadenopathy (100%) followed by
hepatomegaly (72%) and splenomegaly (48%). The commonest infection
was pneumonia (84%) followed by abscesses (55%) involving lungs, liver,
subcutaneous tissue; osteomyelitis (15%); urinary tract infections; otitis
media and CNS infections. Organisms isolated from blood, stool and pus of
infected lesions included bacteria- Mycobacterium tuberculae (50%),
Staphylococci (24%), Klebsiella (16%) and fungi- Aspergillus (13%), Candida
(26%). Biopsies done in 36% patients from lymph node, skin, lung and liver
showed non caseating granulomatous inﬂammation. Diagnosis was based
on reduced nitroblue tetrazolium test (NBT) between 0-5% in all patients
and conﬁrmed by dihydrorhodamine (DHR) assay in 84% patients. 18
families were screened. All patients received antibiotics, 80% received AKT,
76% received Antifungals and all received antifungal and antibacterial
prophylaxis. 4 patients have succumbed to the illness and 13 patients are
lost to follow-up. 7 patients inherited CGD in an X-linked recessive fashion.
Genetic mutation analysis has been done in 22 patients.
Conclusion: CGD is a not uncommon in India. The commonest mode of
presentation was Pneumonia, skin and subcutaneous abscesses, lymph-
adenitis and osteomyelitis. Mycobacteria, Staphylococcus Aureus, Klebsi-
ella, Aspergillus, Candida, and Gram negative bacilli were the commonest
organism isolated in our series. Infection with Aspergillus, Burkholderia
Cepacia, Serratia Marcescens, Nocardia should prompt work up for CGD.
All children with CGD should be given routine chemoprophylaxis with
Septran and Itraconazole. Families should be screened and counselled
during future conceptions.PID_ALP_ID-1_V1.4
AN INTERESTING CASE OF FEVER-NEONATAL ONSET MULTI SYSTEMIC
INFLAMMATORY DISORDER
Mohammed Naseer, P. Taur, A. Parmar, P. Kanvinde, A. Hedge,
M. Madkaikar, R.G. Mansky, S. Mudaliar, A. Swami, N. Shah,
B. Agarwal, M. Desai. Bai Jerbai Wadia Hospital for Children, India
Background: Neonatal onset multisystem inﬂammatory disease (NOMID)
is the most severe phenotype in spectrum of Cryopyrin (NLRP3/NALP3)
associated periodic syndromes (CAPS) associated with chronic IL-1B over
production. Mutated NLRP3 causes constitutive activation of NLRP3
Inﬂammasome which over produces IL-1B. The role of IL1 B in NOMID has
been demonstrated in clinical trials using IL1 blocking agents that cause
rapid resolution of disease manifestations.1
Case Summary: A 16 months old male child presented with complaints of
fever and rash since day 1 of life and delayed development. Fever is almost
always associated with rash. Rash is urticarial, truncal with itching. At 7
months child was noticed to have anemia with hepatosplenomegaly and
neuroimaging was s/o mild cerebral atrophy with communicating hydro-
cephalus. Patient had h/o 3-4 episodes of pneumonia too. Examination
revealed overhanging forehead, hypertelorism, depressed nasal bridge.
Child had pallor, rash, hepatosplenomegaly with generalized hypotonia. A
differential of primary immune deﬁciency disease v/s inﬂammatory dis-
order v/s mastocytosis v/s storage disorder was evaluated. His baseline
investigations were within normal range. MRI was s/o mild generalized
atrophy with dilated lateral ventricles. Bone marrow aspiration was done
to r/o mastocytosis. Liver biopsy had no evidence of storage disease.
Lymphocyte subset and DNT cell analyses were within normal range. After
ruling out the above differentials a periodic inﬂammatory syndrome was
suspected. Cryopyrin mutation analysis at NIH suggested mutation in
CIAS1 G755R region. This mutation is interesting as it is exon 4, which is
not a common mutation.Discussion: A basic innate response to any pathogen is Inﬂammasome
formation.2 In CAPS, mutated NALP3 is constitutively activated resulting in
increased assembly of NALP3 infalmmasome and active caspase 1. Active
caspase 1 cleaves inactive pro IL 1 B to its active form. NOMID has onset in
neonatal or early infancy. It has continuous ﬂares with involvement of skin
(rash), eye (conjunctivitis), joints, ears, and meninges.1 Distinguishing
features being chronic meningitis, SNHL and a characteristic facies. IL 1
receptor antibodies (Anakinra) are used in the treatment. With treatment,
systemic inﬂammation, conjunctivitis, arthritis and cochlietis can be pre-
vented. Leptomeningitis can be fully reversible.
Conclusion: NOMID is a CAPS presenting with fever since early life. The
cardinal features are fever with rash since day 1 of life with continuous
ﬂares. The present case of NOMID had an exon 4, rather than exon 3 where
most of the identiﬁed mutations are seen. After differentiating it from
immunodeﬁciency disorder and since the pathophysiology of NOMID in-
volves IL-1 B over production, IL1 antibodies are used in treatment, which
cause prevention of end organ damage.
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TOPIC: LEUKOCYTE ADHESION DEFICIENCY TYPE 1 e A TERTIARY CARE
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P. Keni, M. Madkaikar, M. Gupta, S. Mhatre, S. Garg, B. Agarwal,
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Introduction: Leukocyte adhesion defect (LAD) is a rare, autosomal
recessive primary immunodeﬁciency disorder of phagocytes with defec-
tive aggregation at the site of infection due to the absence of surface
integrins. Diagnosis is based primarily on ﬂow cytometric analysis of
neutrophils for the surface expression of CD11, CD18 and CD15s. More than
300 cases have been described for LAD 1 worldwide, while for LAD 2 and
LAD 3; there are less than 10 cases each.
Materials and methods: Analysis of clinical and laboratory proﬁle of 6
cases of LAD type 1 seen at our institute over a period of 5 years (2011-2016)
Demographic data was collected with respect age, consanguinity, com-
munity and residence. Taking an average of WBC count on presentation,
mean WBC count was calculated. Microorganisms identiﬁed from
respective in situ sites were documented. The CD 11, CD18 and CD15s
expression identiﬁed with ﬂow cytometry analysis. The data obtained
being tabulated and expressed in graphical form.
Results: The age of presentationwas from 1 to 6months. Fivewere born of
consanguineous marriage. 4 patients were from Maharashtra and 2 from
Gujarat. 3 patients belonged to Hindu Maratha, 2 to Muslim Sunni and one
to Hindu Kathiawadii community. All had delayed separation of umbilical
cord on questioning. Average neutrophil count at presentationwas 67,788/
mm3. Of the 6 cases, 4 had gram negative septicemia. Pseudomonas was
isolated from blood culture in two cases and ET culture in one. In one
patient, Klebsiella was isolated in urine and enterococci in blood. Axillary
and inguinal ulcers were seen in one and necrotizing otitis externa in the
another patient. All cases were severe LAD type 1 with CD 18 and CD11 a, b
and c ranging from 0% in 4 and 1.6% in one. 3 patients expired from
septicemia and one was lost to follow up. One case is hospitalized with
necrotizing otitis externa with LMN facial palsy. One case is posted for
transplantation at AIIMS, New Delhi.
Conclusion: LAD is a rare disease characterized by lack of cell surface
expression of integrins, which are essential for adhesion of leukocytes to
endothelial cells and chemotaxis. LAD-1 caused by lack of CD-18 integrins
on the neutrophil surface has the worst prognosis and most patients die
within 1st year due to severe infections;< 1% expression are clinically
severe, whereas those with 2.5-10% expression are moderate to mild. In
LAD-II, the neutrophils lack the membrane carbohydrate Sialyl-Lewis X
required for adherence to activated endothelial cells. LAD-III is associated
with defect in activation of Rap 1 protein.
LAD-I is characterized by delayed shedding of umbilical stump, recurrent
bacterial infections of the skin, leucocytosis, absence of pus and poor
wound healing. All patients in present study had delayed separation > 10
days (Mean 5.8-10.9). Commonest organisms isolated are Staphylococcus
aureus and enteric gram negative bacilli and in our study pseudomonas
was in majority.
Abstracts / Pediatric Hematology Oncology Journal 1 (2016) S1eS33 S19Conﬁrmation of diagnosis in LAD-I requires demonstration of absence of
CD18 and associated alpha subunit of CD11a, CD11b, CD11c on ﬂow
cytometry. 4 of 6 patients had complete absence of the integrins. Differ-
ential diagnosis include Interleukin-1 receptor associated kinase deﬁ-
ciency, Hyper IgE syndrome and leukemoid reaction. The only corrective
treatment is hematopoietic stem cell transplantation. Reported survival in
a largest series is5 years after follow up was 75%. These patients die in
childhood if transplantation is not done and if the transplantation is car-
ried out before serious infections, the prognosis is very good.
LAD is a rare form of congenital immune deﬁciency to be suspected in a
child with delayed fall of umbilical cord, highWBC count with neutrophilia
and consanguineous marriage. High index of suspicion and early diagnosis
before infection sets in is important as mortality rate is high. Pseudomonas
was most common organism isolated in the present study.Figure 1. No correlation between serum ferritin and cardiac ironload.ĂRBC Disorders
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ACQUIRED APLASTIC ANAEMIA IN CHILDREN e OPTIMAL OUTCOMES
DEPEND ON OPTIMAL DELIVERY OF IMMUNOSUPPRESSIVE THERAPY
Dhaarani Jayaraman, Ramya Uppuluri, Divya Subburaj, Venkateshwaran,
Revathi Raj. Department of Paediatric Haematology, Oncology and Blood and
Marrow Transplantation, Apollo Speciality Hospital, Chennai, India
Background: Acquired aplastic anemia (AA) is a haematological emer-
gency in children and we have gained enormous knowledge about the
pathogenesis and immune mediated self-destruction of stem cells and
immunosuppressive therapy. Due to its rarity, we have limited data of this
entity, especially, its course and outcome in resource limited countries.
Patients and methods: The case records of children who had been diag-
nosed to have AA since 2002 at our centre were reviewed. The diagnosis of
AA was made in children with pancytopenia without organomegaly and
conﬁrmed by hypocellular bone marrow showing decreased expression of
all three hematopoietic lineages. Clinical ﬁndings including dysmorphism,
thumb abnormalities, congenital malformations and skin hyperpigmen-
tation were noted down. Mitomycin C induced chromosomal instability to
rule out Fanconi anaemia, Ham's test to look for paroxysmal nocturnal
haemoglobinuria and chromosomal analysis to look for complex karyo-
typic abnormalities seen in myelodysplastic syndrome were documented
in all patients.
After initial stabilization, the option of haematopoietic stem cell trans-
plantation (HSCT) was offered to all those who had matched related do-
nors. If not, immunosuppressive therapy was delivered within twomonths
from diagnosis after the child was infection free. A combination of 40mg/
kg/day of Horse derived antithymocyte globulin (ATGAM) and methyl-
prednisolone at 2 mg/kg/day were started for the ﬁrst 4 days through a
central venous catheter. Oral cyclosporine and G-CSF were started on the
ﬁfth day and since 2015 Eltrombopag was added to the IST regimen.
Revolade and GCSF were continued for about 8 to 12 weeks and cyclo-
sporine from 6 to 12 months. All patient received Voriconazole and
Acyclovir prophylaxis till neutrophil recovery to 1000.
Results: A total of 109 children had been diagnosed as AA, of whom, 42
had acquired AA. Themean age of childrenwith acquired AAwas 8.16 years
(2-15 yrs). Boys were twice more commonly affected (ratio M: F ¼ 2:1).
Details are listed in table 1.
Of the 41, 21 underwent HSCT as they had fully matched related donor and
20 children received IST. Of the 20 children who received ATG, 10 children
(70%) had complete remission in a median duration of 78 days. Two of the
three non responderswere treated with second IST and all three succumbed
to the illness. One child developed acute myeloid leukaemia after achieving
partial remission and was salvaged with HSCT, and 1 more non responder
had an unrelated HSCT and is doing well. One child has suffered a relapse
after a durable remission of over 18 months off immunosuppression. The 21
children who have been transplanted have an overall survival rate of 77 %.
Conclusion: Immunosuppressive regimen including Horse ATGAM,
Methyl prednisolone, Cyclosporine, GCSF and Eltrombopag along with
adequate and meticulous supportive care including neutropenic care,
prompt infection management and the use of irradiated and leukode-
pleted blood products results in a 70% response rate and should be offered
to all children with aplastic anaemia with no matched family donor. Theaddition of Elthrombopag has resulted in early recovery of all three cell
lines and must be added to the IST protocol in children.
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DISCORDANT BEATS e A PROSPECTIVE STUDY OF CARDIAC MRI TO
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Venakateswaran1, Ravikanth Balaji 1, S. Premsekar 2, Revathi Raj 1.
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Transplantation, Apollo Speciality Hosital, Chennai, India; 2VHS Thalassaemia
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Introduction: Advances in blood banking has ensured optimal delivery of
monthly transfusion needed to save the lives of about 10,000 new thal-
assaemia children born each year in our country. The burden of iron che-
lation has now increased as these children survive into their second and
third decade of life. Cardiac failure secondary to myocardial haemoside-
rosis is the most common cause of mortality in these patients. Our study
has been done to evaluate the prevalence and severity of cardiac ironload
in children with beta thalassemia major and the effectiveness of serum
ferritin as a marker of iron overload.
Patients and Methods: We conducted a prospective study from the year
2015-2016 where we performed T2* cardiac magnetic resonance (CMR),
serum ferritin levels and pulmonary artery pressures by echocardiography
in 100 patients with transfusion dependent beta thalassaemia major. The
study had been approved by IRB at the VHS centre and informed consent
was obtained from all of these families. The median age of our patients was
14 (range 7 TO 33 years) with 51% of them being female. The mean serum
ferritin level was 2520.78 +-223.454 ng/ml. High iron overload with a
serum ferritin of over 2500 was seen in 37% of our patients. The 29% pa-
tient group that had less than 1000 ferritin were considered to be chelated
optimally as per international guidelines. A cardiac T2*of over 20 milli-
seconds was taken as a marker of heart free of iron overload.
The mean cardiac MRI T2* was 12.73 +-2.436 milliseconds. About 70% of
our patients had moderate myocardial iron overload (T2* 10-20 ms) and
24% had severe iron overload (T2* <10ms). The mean pulmonary arterial
pressure was 35.96+-8.3 mm of Hg. About 76% of the patients were on a
single drug chelation therapy at the time of evaluation. Following the
cardiac iron status they have been started on combination chelation
therapy consisting of deferasirox and deferiprone.
We found no signiﬁcant correlation (r¼0.014, p¼0.23) between the serum
ferritin levels and myocardial ironload. The most signiﬁcant ﬁnding was
that 38 % (11/29) of our patients with serum ferritin < 1000 had severe
cardiac iron load. A signiﬁcant correlation could also be established be-
tween pulmonary arterial pressures and cardiac MRI T2 *(r¼1.2, p
¼0.0024).
